site:markets.businessinsider.com

20h

Agentic AI Runs Where Enterprise Software Runs: Embedded LLM Launches TokenVisor Spaces for AMD-Powered AI Clouds at AMD Advancing AI 2026

The announcement aligns to the event's focus on AI infrastructure, enterprise deployment, developers, customers, and partners ...

19h

Navitas and Magnachip Announce Strategic Partnership to Accelerate High-Voltage and Ultra-High-Voltage Silicon Carbide Adoption

License agreement provides Magnachip access to Navitas’ GeneSiC™ Gen 4 and Gen 5 SiC technologies spanning 1200 V, 2300 V, ...

22h

Evolution Metals Is Executing on the Defense Supply Chain the White House is Pushing for (NASDAQ: EMAT)

WSW, NY, July 23rd, 2026, FinanceWireThe race to build a rare-earth magnet supply chain outside China is heating up, and ...

21h

Ladris Technologies Unveils Prime, the First Autonomous Decision-Support System for Evacuation and Incident Management

Ladris Technologies today announced the activation of Ladris Prime, an autonomous decision-support system that calculates evacuation orders for incident commanders in real time. Prime is Ladris' first ...

Frequency Electronics Inc. Announces Contract Awards Valued at Approximately $18 million

Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM), a leading provider of precision timing and frequency control products for space and terrestrial applications, is pleased to announce ...

Scouting America Kicks-Off the 2026 National Jamboree at the Summit Bechtel Reserve in West Virginia

Scouting America officially kicked-off the 2026 National Jamboree at the Summit Bechtel Reserve, welcoming 15,000 Scouts, Venturers, Explorers, adult leaders, staff volunteers, and community ...

Business Insider

FTSE 100 Markets Movers

Melissa Alcruz Earns 2026 Global Recognition Award for Transformative Brand Leadership and Strategic Marketing Excellence

Melissa Alcruz has received a 2026 Global Recognition Award for her exceptional leadership in marketing and brand strategy, ...

Revolution Medicines’ New Drug Application for Daraxonrasib Accepted for Review by U.S. FDA for Previously Treated Metastatic Pancreatic Cancer

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that the U.S. Food and Drug ...